Reconsidering the scope of US state laws allowing pharmacist substitution of generic drugs

BMJ. 2020 Jun 23:369:m2236. doi: 10.1136/bmj.m2236.

Authors

Jonathan J Darrow¹, Jessica E Chong¹, Aaron S Kesselheim¹

Affiliation

¹ Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.

PMID: 32576554
DOI: 10.1136/bmj.m2236

No abstract available

MeSH terms

Drug Costs / legislation & jurisprudence*
Drug Substitution*
Drugs, Generic* / economics
Humans
Legislation, Pharmacy
Pharmacists / legislation & jurisprudence*
Therapeutic Equivalency
United States

Substances

Drugs, Generic